Prevalence of serum neutralizing antibodies to adenovirus type 5 (Ad5) and 41 (Ad41) in children is associated with age and sanitary conditions

Neutralizing antibody (NAb) can dampen the immunogenicity of adenovirus (Ad) vector-based vaccine. Vector systems based on human adenovirus type 41 (Ad41) have been constructed and used to develop recombinant vaccines. Here, we attempted to study the seroprevalence of NAbs to Ad5 and Ad41 among chil...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Wei-Xiong, Zou, Xiao-Hui, Jiang, Shuang-Ying, Lu, Nan-Nan, Han, Mei, Zhao, Jian-Hai, Guo, Xiao-Juan, Zhao, Sheng-Cang, Lu, Zhuo-Zhuang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7115419/
https://www.ncbi.nlm.nih.gov/pubmed/27682509
http://dx.doi.org/10.1016/j.vaccine.2016.09.043

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7115419/
https://www.ncbi.nlm.nih.gov/pubmed/27682509
http://dx.doi.org/10.1016/j.vaccine.2016.09.043

Ejemplares similares